MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/heartjnl-2013-304172

Медицинская библиотека · Heart (British Cardiac Society) · 2013

Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.

Carrasco-Chinchilla Fernando, Muñoz-García Antonio J, Domínguez-Franco Antonio, Millán-Vázquez Gloria, Guerrero-Molina Alicia, Ortiz-García Carmen, Enguix-Armada Alfredo, Alonso-Briales Juan H, Hernández-García Jose M, de Teresa-Galván Eduardo, Jiménez-Navarro Manuel F

СтатьяРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

Determine whether remote ischaemic postconditioning (RIP) protects against percutaneous coronary intervention-related myocardial infarction (PCI-MI).

DESIGN

Single-centre, randomised, blinded to the researchers, clinical trial. ClinicalTrials.gov (NCT 01113008).

SETTING

Tertiary hospital centre.

PATIENTS: 232 patients underwent elective PCI for stable or unstable angina.

INTERVENTIONS: Patients were randomised to RIP (induction of three 5-min cycles of ischaemia in the arm after the PCI) versus placebo.

MAIN OUTCOME MEASURES: The primary outcome measure was the peak 24-h troponin I level. PCI-MI was defined by an elevation of troponin values >3 or >5 of the 99th percentile according to the classical or the new definition. The secondary outcome measure was hospital admission, PCI for stable angina or acute coronary syndrome and mortality after 1 year of follow-up. The use of RIP in diabetic patients was specifically studied.

RESULTS

The mean age was 64.6 years, and 42% were diabetic. The peak troponin in the RIP patients was 0.476 vs 0.478 ng/mL (p=0.99). PCI-MI occurred in 36% of the RIP patients versus 30.8% in the placebo group (p=0.378). Diabetic RIP patients had more PCI-MI (new definition): OR 2.7; 95% CI 1.10 to 6.92; p=0.027. The secondary outcome measure was seen in 11.7% of the RIP patients versus 10.8% in the placebo group (p=0.907).

CONCLUSIONS

RIP did not reduce the damage associated with elective PCI or cardiovascular events during the follow-up. The diabetic population who underwent RIP had more PCI-MI.

Для цитирования: Carrasco-Chinchilla Fernando, Muñoz-García Antonio J, Domínguez-Franco Antonio, Millán-Vázquez Gloria, Guerrero-Molina Alicia, Ortiz-García Carmen, Enguix-Armada Alfredo, Alonso-Briales Juan H, Hernández-García Jose M, de Teresa-Galván Eduardo, Jiménez-Navarro Manuel F. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.. Heart (British Cardiac Society). 2013. DOI: 10.1136/heartjnl-2013-304172.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.